Literature DB >> 20978295

[Epidemiology of erectile dysfunction. Risk factors].

Rafael Prieto Castro1, Pablo Campos Hernández, Rafael Robles Casilda, Jesús Ruíz García, María José Requena Tapia.   

Abstract

In 1993 the NIH (National Institute of Health) Consensus Conference on Impotence defined erectile dysfunction as the permanent incompetence to start or maintain an erection enough to enable satisfactory sexual intercourse. Erectile dysfunction (ED) is a frequent disorder that affects negatively quality of life of males suffering it. Its prevalence varies between different countries, cultures and races. The first population studies published date from early 90's and still keep their validity. All of them show the influence of age on prevalence of ED, as well as its close relationship with cardiovascular diseases. Depending on the definition used and study design prevalence varies from 10 to 52%, mainly in men between 40-70 years, with an incidence in western countries between 25-30 new cases per 1000 inhabitants year.

Entities:  

Mesh:

Year:  2010        PMID: 20978295

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  7 in total

1.  Prevalence and factors associated with erectile dysfunction in patients with chronic kidney disease on conservative treatment.

Authors:  M R Costa; V C Ponciano; T R Costa; A M de Oliveira; C P Gomes; E C de Oliveira
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

2.  A novel method to establish a rat ED model using internal iliac artery ligation combined with hyperlipidemia.

Authors:  Chao Hu; Feixiang Wang; Yehao Dong; Jican Dai
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

3.  Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats.

Authors:  Lin Wang; Yongde Xu; Huixi Li; Hongen Lei; Ruili Guan; Zhezhu Gao; Zhongcheng Xin
Journal:  J Cell Mol Med       Date:  2015-03-17       Impact factor: 5.310

4.  Superselective embolization for high-flow priapism refractory to medical and surgical treatments.

Authors:  Yonghua Bi; Mengfei Yi; Zepeng Yu; Xinwei Han; Jianzhuang Ren
Journal:  BMC Urol       Date:  2020-06-30       Impact factor: 2.264

5.  Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction.

Authors:  Vladimir Bykov; Evgenia Gushchina; Sergey Morozov; Natalia Zhuravskaya; Kirill Kryshen; Valery Makarov; Aleksandr Matichin; Alena Zueva
Journal:  Sex Med       Date:  2022-01-08       Impact factor: 2.491

6.  Erectile Dysfunction After Surgical Treatment of Lung Cancer: Real-World Evidence.

Authors:  Ming-Szu Hung; Yi-Chuan Chen; Tsung-Yu Huang; Dong-Ru Ho; Chuan-Pin Lee; Pau-Chung Chen; Yao-Hsu Yang
Journal:  Clin Epidemiol       Date:  2020-09-11       Impact factor: 4.790

7.  Spanish Cross-Cultural Validation of the Electronic Version of the International Index of Erectile Function-5 (IIEF-5).

Authors:  Raquel Lizarraga-Limousin; Esther M Medrano-Sánchez; Esther Díaz-Mohedo; Lorena Vergara-de-Carlos
Journal:  Int J Environ Res Public Health       Date:  2022-03-07       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.